Procter & Gamble Company (The) $PG Shares Sold by Country Club Bank

Country Club Bank lowered its stake in Procter & Gamble Company (The) (NYSE:PG) by 19.1% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 58,127 shares of the company’s stock after selling 13,755 shares during the quarter. Country Club Bank’s holdings in Procter & Gamble were worth $9,292,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Kingstone Capital Partners Texas LLC raised its position in shares of Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Northern Trust Corp increased its stake in Procter & Gamble by 0.8% during the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in shares of Procter & Gamble by 3.5% in the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after acquiring an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Procter & Gamble by 6.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after acquiring an additional 1,018,865 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 13,039 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the sale, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

PG has been the topic of a number of research reports. BNP Paribas restated an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a report on Friday, August 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Saturday, September 27th. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research report on Tuesday, September 23rd. Barclays cut their price objective on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $173.11.

Procter & Gamble Stock Down 1.2%

NYSE:PG opened at $150.47 on Tuesday. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43. The stock’s fifty day moving average is $155.38 and its two-hundred day moving average is $159.84. The stock has a market capitalization of $352.17 billion, a price-to-earnings ratio of 23.11, a price-to-earnings-growth ratio of 4.02 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the previous year, the business earned $1.40 EPS. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.